ID: ALA4864648

Max Phase: Preclinical

Molecular Formula: C36H45N9O4

Molecular Weight: 667.81

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  N=C(N)NCCCC[C@H](NC(=O)[C@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CCN)C(N)=O

Standard InChI:  InChI=1S/C36H45N9O4/c37-18-17-32(46)43-31(21-26-22-42-28-11-5-4-10-27(26)28)35(49)45-30(20-23-13-15-25(16-14-23)24-8-2-1-3-9-24)34(48)44-29(33(38)47)12-6-7-19-41-36(39)40/h1-5,8-11,13-16,22,29-31,42H,6-7,12,17-21,37H2,(H2,38,47)(H,43,46)(H,44,48)(H,45,49)(H4,39,40,41)/t29-,30-,31-/m0/s1

Standard InChI Key:  QJRIMTCEQOBAQE-CHQNGUEUSA-N

Associated Targets(Human)

Ephrin type-A receptor 4 2022 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 667.81Molecular Weight (Monoisotopic): 667.3595AlogP: 1.56#Rotatable Bonds: 18
Polar Surface Area: 234.10Molecular Species: BASEHBA: 6HBD: 9
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 12#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.19CX Basic pKa: 11.82CX LogP: 0.88CX LogD: -2.86
Aromatic Rings: 4Heavy Atoms: 49QED Weighted: 0.04Np Likeness Score: -0.03

References

1. Baggio C, Kulinich A, Dennys CN, Rodrigo R, Meyer K, Ethell I, Pellecchia M..  (2021)  NMR-Guided Design of Potent and Selective EphA4 Agonistic Ligands.,  64  (15.0): [PMID:34293864] [10.1021/acs.jmedchem.1c00608]

Source